LESSON 1 OF 2
Metabolism and the growth hormone axis
By the end you can
- Describe the gut hormones behind GLP-1 research
- Trace the growth hormone axis from brain to liver
- Match products to each system
Gut hormones and metabolism
After a meal, the gut and pancreas release peptide hormones that tell the body food has arrived. GLP-1 and GIP signal the pancreas to release insulin, and GLP-1 also acts on appetite centers in the brain. Amylin, released with insulin, adds a fullness signal. Glucagon, also from the pancreas, works the other way: it is released between meals to free up stored energy.
This system is the most active area of peptide research today. Semaglutide targets the GLP-1 receptor, tirzepatide targets GLP-1 and GIP, and retatrutide adds the glucagon receptor. Cagrilintide is a long-acting amylin analog.
The growth hormone axis
Growth hormone (GH) is controlled by a chain of signals. The hypothalamus in the brain releases GHRH, which tells the pituitary gland to release GH. GH travels to the liver, which makes IGF-1, the hormone behind many of GH's effects. A brake called somatostatin keeps the system in check.
A second signal, ghrelin, also pushes the pituitary to release GH through its own receptor. Research peptides target this axis at two points: GHRH analogs (sermorelin, CJC-1295, tesamorelin) and ghrelin mimics, often called GH-releasing peptides or GH secretagogues (ipamorelin, GHRP-2, GHRP-6).
Swipe to see the full diagram →
Key terms
- GLP-1
- A gut hormone released after eating that signals insulin release and fullness.
- GIP
- A second gut hormone that also signals insulin release.
- Amylin
- A hormone released with insulin that adds a fullness signal.
- GHRH
- Growth hormone-releasing hormone, the brain's signal to release GH.
- Secretagogue
- A substance that causes a gland to release (secrete) a hormone.
- IGF-1
- Insulin-like growth factor 1, made by the liver in response to GH.
Remember
- GLP-1, GIP, amylin and glucagon form the core of metabolic peptide research.
- GH release runs hypothalamus → pituitary → liver (IGF-1).
- GHRH analogs and ghrelin mimics act at different points on the same axis.